Stromal expression of MMP-13 is required for melanoma invasion and metastasis

Journal of Investigative Dermatology

Volumn 129, Issue 11, 2009, Pages 2686-2693

  Zigrino, Paola ^a   Kuhn, Isolde ^a   Bäuerle, Tobias ^b   Zamek, Jan ^a   Fox, Jay W ^c   Neumann, Susanne ^a   Licht, Alexander ^d   Schorpp Kistner, Marina ^d   Angel, Peter ^d   Mauch, Cornelia ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Department of Medical Physics in Radiology ^*  (Germany)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Division of Signal Transduction and Growth Control   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CANCER INVASION; CELL DENSITY; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; HEART; INJECTION; LIVER; LUNG; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; STROMA CELL; TUMOR GROWTH; TUMOR VOLUME; WILD TYPE;

ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MACROPHAGES; MATRIX METALLOPROTEINASE 13; MELANOMA; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; SKIN NEOPLASMS; STROMAL CELLS;

EID: 70350072797     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.130     Document Type: Article

References (35)

1. Airola K, Johansson N, Kariniemi AL, Kahari VM, Saarialho-Kere UK (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109:225-231
2. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL et al. (1999) Expression of collagenases-1 and-3 and their inhibitors TIMP-1 and-3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80:733-743
3. Akgul B, Pfefferle R, Marcuzzi GP, Zigrino P, Krieg T, Pfister H et al. (2006) Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice. Exp Dermatol 15:35-42
4. Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R et al. (2006) Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis. Rheumatology (Oxford) 45: 303-307 (Pubitemid 43372845)
5. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621-628
6. Corte MD, Gonzalez LO, Corte MG, Quintela I, Pidal I, Bongera M et al. (2005) Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers 20:242-248
7. Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M et al. (2008) Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc Natl Acad Sci USA 105:15040-15045
8. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS et al. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178:5288-5295
9. Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V et al. (2005) Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 65:4134-4146
10. Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH, Teurich S et al. (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol 126:486-496
11. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-1051
12. Itoh Y, Binner S, Nagase H (1995) Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308(Part 2):645-651
13. Kahari VM, Johansson N, Grenman R, Airola K, Saarialho-Kere U (1998) Expression of collagenase-3 (MMP-13) by tumor cells in squamous cell carcinomas of the head and neck. Adv Exp Med Biol 451:63-68
14. Kiessling F, Heilmann M, Vosseler S, Lichy M, Krix M, Fink C et al. (2003) Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging. Int J Cancer 104:113-120
15. Kim MH, Kitson RP, Albertsson P, Nannmark U, Basse PH, Kuppen PJ et al. (2000) Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol 164: 5883-5889 (Pubitemid 30389834)
16. Kuivanen T, Ahokas K, Virolainen S, Jahkola T, Holtta E, Saksela O et al. (2005) MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype. Virchows Arch 447:954-960
17. Kurschat P, Wickenhauser C, Groth W, Krieg T, Mauch C (2002) Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatino-lytic enzyme in malignant melanoma by in situ zymography. J Pathol 197:179-187
18. Lafleur MA, Drew AF, de Sousa EL, Blick T, Bills M, Walker EC et al. (2005) Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer 114:544-554
19. Loffek S, Zigrino P, Angel P, Anwald B, Krieg T, Mauch C (2005) High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol 124:638-643
20. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201-210
21. Metheny-Barlow LJ, Li LY (2003) The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 13:309-317
22. Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR et al. (2001) Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61:7091-7100
23. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S (2001) High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma. Melanoma Res 11:157-166
24. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S (2005) High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 11:5158-5166
25. Obermueller E, Vosseler S, Fusenig NE, Mueller MM (2004) Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 64:7801-7812
26. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y et al. (2004) Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895
27. Timar J, Dome B, Fazekas K, Janovics A, Paku S (2001) Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res 7:85-94
28. Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE (2005) Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 65:1294-1305
29. Wandel E, Grasshoff A, Mittag M, Haustein UF, Saalbach A (2000) Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Exp Dermatol 9:34-41
30. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792
31. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM (1997) Intestinal tumorigenesis is suppressed in mice lacking the metallopro-teinase matrilysin. Proc Natl Acad Sci USA 94:1402-1407
32. Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM et al. (2008) FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci USA 105:10167-10172
33. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S et al. (2008) Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 8:83
34. Zigrino P, Loffek S, Mauch C (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87:321-328
35. Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M et al. (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279:27633-27645